Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moritz Maas

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Expert Opinion on Biological Therapy|February 12, 2021
Combination of immune checkpoint inhibitors and tyrosine kinase inhibitors for the treatment of renal cell carcinomaViktoria Stühler, Steffen Rausch, Jan Moritz Maas, et al.
Asian Journal of Andrology|August 25, 2017
Circulating tumor cells and their role in prostate cancerMoritz Maas, Miriam Hegemann, Steffen Rausch, et al.
Clinical Nuclear Medicine|April 8, 2026
Excellent Response to Combined 223Ra-dichloride and Enzalutamide After Failure of 177Lu-PSMA Radioligand TherapyEduardo Calderón, Magdalena Sophie Späth, Moritz Maas, et al.
Journal of Clinical Medicine|February 11, 2023
A Peritoneal Purse-String Suture Prevents Symptomatic Lymphoceles in Retzius-Sparing Robot-Assisted Radical ProstatectomyNiklas Harland, Mohammed Alfarra, Eva Erne, et al.
Scientific Reports|June 25, 2026
Nectin-4 expression in clear cell renal cell carcinomaKyra Klein, Steffen Rausch, Veronika Bahlinger, et al.
Asian Journal of Andrology|December 30, 2017
Current concepts and trends in the treatment of bone metastases in patients with advanced prostate cancerMiriam Hegemann, Moritz Maas, Steffen Rausch, et al.
World Journal of Urology|February 26, 2022
Prognostic impact of complete metastasectomy in metastatic renal cell carcinoma in the era of immuno-oncology-based combination therapiesViktoria Stühler, Lisa Herrmann, Moritz Maas, et al.
World Journal of Urology|February 11, 2021
Retrospective German claims data study on initial treatment of bladder carcinoma (BCa) by transurethral bladder resection (TURB): a comparative analysis of costs using standard white light- (WL-) vs. blue light- (BL-) TURBTilman Todenhöfer, Moritz Maas, Miriam Ketz, et al.
Expert Review of Molecular Diagnostics|May 1, 2018
Molecular markers in disease detection and follow-up of patients with non-muscle invasive bladder cancerMoritz Maas, Simon Walz, Viktoria Stühler, et al.
Urologia Internationalis|August 17, 2017
Is Endoscopic Vasectomy Just a Dream: An ex vivo Study on Feasibility and Reliability of Endoluminal Occlusion of Porcine Vas DeferensDaniel Schlager, Moritz Maas, Simon Hein, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Expert Opinion on Biological Therapy|February 12, 2021
Combination of immune checkpoint inhibitors and tyrosine kinase inhibitors for the treatment of renal cell carcinomaViktoria Stühler, Steffen Rausch, Jan Moritz Maas, et al.
Asian Journal of Andrology|August 25, 2017
Circulating tumor cells and their role in prostate cancerMoritz Maas, Miriam Hegemann, Steffen Rausch, et al.
Clinical Nuclear Medicine|April 8, 2026
Excellent Response to Combined 223Ra-dichloride and Enzalutamide After Failure of 177Lu-PSMA Radioligand TherapyEduardo Calderón, Magdalena Sophie Späth, Moritz Maas, et al.
Journal of Clinical Medicine|February 11, 2023
A Peritoneal Purse-String Suture Prevents Symptomatic Lymphoceles in Retzius-Sparing Robot-Assisted Radical ProstatectomyNiklas Harland, Mohammed Alfarra, Eva Erne, et al.
Scientific Reports|June 25, 2026
Nectin-4 expression in clear cell renal cell carcinomaKyra Klein, Steffen Rausch, Veronika Bahlinger, et al.
Asian Journal of Andrology|December 30, 2017
Current concepts and trends in the treatment of bone metastases in patients with advanced prostate cancerMiriam Hegemann, Moritz Maas, Steffen Rausch, et al.
World Journal of Urology|February 26, 2022
Prognostic impact of complete metastasectomy in metastatic renal cell carcinoma in the era of immuno-oncology-based combination therapiesViktoria Stühler, Lisa Herrmann, Moritz Maas, et al.
World Journal of Urology|February 11, 2021
Retrospective German claims data study on initial treatment of bladder carcinoma (BCa) by transurethral bladder resection (TURB): a comparative analysis of costs using standard white light- (WL-) vs. blue light- (BL-) TURBTilman Todenhöfer, Moritz Maas, Miriam Ketz, et al.
Expert Review of Molecular Diagnostics|May 1, 2018
Molecular markers in disease detection and follow-up of patients with non-muscle invasive bladder cancerMoritz Maas, Simon Walz, Viktoria Stühler, et al.
Urologia Internationalis|August 17, 2017
Is Endoscopic Vasectomy Just a Dream: An ex vivo Study on Feasibility and Reliability of Endoluminal Occlusion of Porcine Vas DeferensDaniel Schlager, Moritz Maas, Simon Hein, et al.
Pageof 4